05:11 PM EDT, 03/27/2025 (MT Newswires) -- Portage Biotech ( PRTG ) reported late Thursday encouraging efficacy data in a murine mesothelioma model with PORT-7 given as a single agent or in combination with anti-PD-1 antibody. The data showed both single agent activity, and more than 90% inhibition of tumor growth when PORT-7 was combined with an anti-PD1 antibody in...

05:10 PM EDT, 03/27/2025 (MT Newswires) -- Beam Therapeutics ( BEAM ) said Thursday the US Food and Drug Administration cleared its investigational new drug application for BEAM-302 to treat alpha-1 antitrypsin deficiency, an genetic disorder that affects lungs or liver. Earlier this month, Beam disclosed initial safety and efficacy data from a global phase 1/2 study, showcasing the first...

05:04 PM EDT, 03/27/2025 (MT Newswires) -- AEON Biopharma ( AEON ) said Chief Executive Officer Marc Forth is stepping down to pursue another opportunity, effective April 4. The board named Chairman Jost Fischer as interim CEO, the company said Thursday in a statement. The board is actively considering several qualified candidates, AEON said. Forth will remain on the board,...

05:06 PM EDT, 03/27/2025 (MT Newswires) -- Melissa Baird, Chief Operating Officer, on March 26, 2025, sold 67,687 shares in Hims & Hers Health ( HIMS ) for $2,358,145. Following the Form 4 filing with the SEC, Baird has control over a total of 751,243 Class A common shares of the company, with 751,243 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000106/xslF345X05/wk-form4_1743109451.xml...